入局、研修のご案内

業 績


  ■ 2000年   ■ 2001年   ■ 2002年   ■ 2003年   ■ 2004年   ■ 2005年   ■ 2006年   ■ 2007年
  ■ 2008年   ■ 2009年   ■ 2010年   ■ 2011年   ■ 2012年   ■ 2013年   ■ 2014年   ■ 2015年
  ■ 2016年   ■ 2017年   ■ 2018年   ■ 2019年   ■ 2020年   ■ 2021年   ■ 2022年   ■ 2023年
  ■ 2024年   ■ 2025年   ■   ■   ■   ■   ■   ■

■ Neuro-Tokushima achievements 2018

 

1 論文・著書など（アルファベット順または五十音順）
1A 英文
1A-a. 原著

  1. Argyelan M, Herzallah M, Sako W, DeLucia I, Sarpal D, Vo A, Fitzpatrick T, Moustafa AA, Eidelberg D, Gluck M. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study. Neuroreport 2018;29(7):532-540.

  2. Fujita K, Sako W, Vo A, Bressman SB, Eidelberg D. Disruption of network for visual perception of natural motion in primary dystonia. Hum Brain Mapp 2018;39(3):1163-1174.

  3. Izumi Y, Miyamoto R, Fujita K, Yamamoto Y, Yamada H, Matsubara T, Unai Y, Tsukamoto A, Takamatsu N, Nodera H, Hayashi S, Oda M, Mori A, Nishida Y, Watanabe S, Ogawa H, Uehara H, Murayama S, Sata M, Kaji R. Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study. Front Neurol 2018;9:1099.

  4. Izumi Y, Morino H, Miyamoto R, Matsuda Y, Ohsawa R, Kurashige T, Shimatani Y, Kaji R, Kawakami H. Compound heterozygote mutations in the SIGMAR1 gene in an oldest-old patient with amyotrophic lateral sclerosis. Geriatr Gerontol Int 2018;18(10):1519-1520.

  5. Kaji R, Bhatia K, Graybiel AM. Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin? J Neurol Neurosurg Psychiatry 2018;89(5):488-492.

  6. Kamada M, Kawarai T, Miyamoto R, Kawakita R, Tojima Y, Montecchiani C, D'Onofrio L, Caltagirone C, Orlacchio A, Kaji R. Spastic paraplegia type 31: A novel REEP1 splice site donor variant and expansion of the phenotype variability. Parkinsonism Relat Disord 2018;46:79-83.

  7. Kawarai T, Miyamoto R, Nakagawa E, Koichihara R, Sakamoto T, Mure H, Morigaki  R, Koizumi H, Oki R, Montecchiani C, Caltagirone C, Orlacchio A, Hattori A, Mashimo H, Izumi Y, Mezaki T, Kumada S, Taniguchi M, Yokochi F, Saitoh S, Goto S, Kaji R. Phenotype variability and allelic heterogeneity in KMT2B-Associated disease. Parkinsonism Relat Disord 2018;52:55-61.

  8. Kinoshita M, Nakataki M, Morigaki R, Sumitani S, Goto S, Kaji R, Ohmori T. Turning on the Left Side Electrode Changed Depressive State to Manic State in a Parkinson's Disease Patient Who Received Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report. Clin Psychopharmacol Neurosci 2018;16(4):494-496.

  9. Konno T, Yoshida K, Mizuta I, Mizuno T, Kawarai T, Tada M, Nozaki H, Ikeda SI, Onodera O, Wszolek ZK, Ikeuchi T. Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation. Eur J Neurol 2018;25(1):142-147.

  10. Kuwabara K, Kawarai T, Ishida Y, Miyamoto R, Oki R, Orlacchio A, Nomura Y, Fukuda M, Ishii E, Shintaku H, Kaji R. A novel compound heterozygous TH mutation in a Japanese case of dopa-responsive dystonia with mild clinical course. Parkinsonism Relat Disord 2018;46:87-89.

  11. Kuwabara S, Misawa S, Mori M, Iwai Y, Ochi K, Suzuki H, Nodera H, Tamaoka A, Iijima M, Toda T, Yoshikawa H, Kanda T, Sakamoto K, Kusunoki S, Sobue G, Kaji R; Glovenin-I MMN Study Group. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial. J Peripher Nerv Syst 2018;23(2):115-119.

  12. Matsubara T, Oda M, Takahashi T, Watanabe C, Tachiyama Y, Morino H, Kawakami H, Kaji R, Maruyama H, Murayama S, Izumi Y. Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy. Neuropathology 2019;39(1):47-53.

  13. Matsui N, Nodera H, Kuzume D, Iwasa N, Unai Y, Sakai W, Miyazaki Y, Yamazaki H, Osaki Y, Mori A, Furukawa T, Tsukamoto-Miyashiro A, Shimatani Y, Yamasaki M, Izumi Y, Kusunoki S, Arisawa K, Kaji R. Guillain-Barré syndrome in a local area in Japan, 2006-2015: an epidemiological and clinical study of 108 patients. Eur J Neurol 2018;25(5):718-724.

  14. Mezaki N, Miura T, Ogaki K, Eriguchi M, Mizuno Y, Komatsu K, Yamazaki H, Suetsugi N, Kawajiri S, Yamasaki R, Ishiguro T, Konno T, Nozaki H, Kasuga K, Okuma Y, Kira JI, Hara H, Onodera O, Ikeuchi T. Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy. Neurol Genet 2018;4(6):e292.

  15. Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol 2018;17(6):519-529.

  16. Nakane S, Fujita K, Azuma S, Urushihara R, Kamada M, Harada M, Izumi Y, Kaji R. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2018;172:162-168.

  17. Nodera H, Sogawa K, Takamatsu N, Mori A, Yamazaki H, Izumi Y, Kaji R. Age-dependent texture features in skeletal muscle ultrasonography. J Med Invest 2018;65(3.4):274-279.

  18. Oki R, Izumi Y, Nodera H, Sato Y, Nokihara H, Kanai K, Sonoo M, Urushitani M, Nishinaka K, Atsuta N, Kohara N, Shimizu T, Kikuchi H, Oda M, Ikeda K, Nagai M, Komai K, Kojima Y, Kuzume D, Isose S, Shimohama S, Abe K, Ito H, Noda K, Ishihara T, Morita M, Shimohata T, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; JETALS. The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial. JMIR Res Protoc 2018;7(12):e12046.

  19. Tohnai G, Nakamura R, Sone J, Nakatochi M, Yokoi D, Katsuno M, Watanabe H, Watanabe H, Ito M, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Onodera O, Naruse H, Mitsui J, Takahashi Y, Goto J, Ishiura H, Morishita S, Yoshimura J, Doi K, Tsuji S, Nakashima K, Kaji R, Atsuta N, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS). Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2018;64:158.e15-158.e19.

  20. Torii Y, Sasaki M, Shin MC, Akaike N, Kaji R. Comparison of efficacy and toxicity between botulinum toxin subtypes A1 and A2 in cynomolgus macaques. Toxicon 2018;153:114-119.

  21. Yamamoto N, Yamamoto Y, Izumi Y, Kaji R. Dural Arterivenous Fistula at the Cavernous Sinus Diagnosed by Arterial Spin-labeled Imaging. Intern Med 2018;57(8):1163-1166.

  22. Yamamoto Y, Yamamoto N, Satomi J, Yamaguchi I, Korai M, Kanematsu Y, Takagi Y, Kaji R. Dural arteriovenous fistula in the superior orbital fissure: A case report. Surg Neurol Int 2018;9:95.

  23. Yoshida T, Sueyoshi T, Suwazono S, Kinjo M, Nodera H. Detection of atrophy of dorsal root ganglion with 3-T magnetic resonance neurography in sensory ataxic neuropathy associated with Sjögren's syndrome. Eur J Neurol 2018;25(7):e78-e79.

1A-b. 総説

  1. Dressler D, Bhidayasiri R, Bohlega S, Chana P, Chien HF, Chung TM, Colosimo C, Ebke M, Fedoroff K, Frank B, Kaji R, Kanovsky P, Koçer S, Micheli F, Orlova O, Paus S, Pirtosek Z, Relja M, Rosales RL, Sagástegui-Rodríguez JA, Schoenle PW, Shahidi GA, Timerbaeva S, Walter U, Saberi FA. Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy. J Neurol 2018;265(4):856-862.
  2. Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders. Treatable inherited rare movement disorders. Mov Disord 2018;33(1):21-35.